FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.22-SNAPSHOT  |  FHIR Version n/a  User: [n/a]

38112003: 1 (qualifier value)

    Status: retired, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jan 2023. Module: SNOMED CT core

    Descriptions:

    Id Description Lang Type Status Case? Module
    64719019 One en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
    3442104013 1 (qualifier value) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core
    3442105014 1 en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
    33081000077110 un fr Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT Switzerland NRC maintained Module

    0 descendants.

    Expanded Value Set

    Outbound Relationships Type Target Active Characteristic Refinability Group Values
    un Is a General adjectival modifier false Inferred relationship Some
    un Is a nombre false Inferred relationship Some
    Inbound Relationships Type Active Source Characteristic Refinability Group
    Bacampicillin 25 mg/mL oral suspension Has concentration strength denominator value False un Inferred relationship Some 1
    Bacampicillin 25 mg/mL oral suspension Count of base of active ingredient False un Inferred relationship Some
    Levomethadyl 10 mg/mL oral solution Count of base of active ingredient False un Inferred relationship Some
    Levomethadyl 10 mg/mL oral solution Has concentration strength denominator value False un Inferred relationship Some 1
    Homatropine hydrobromide 2.5 mg/mL eye solution Has concentration strength denominator value False un Inferred relationship Some 1
    Homatropine hydrobromide 2.5 mg/mL eye solution Count of base of active ingredient False un Inferred relationship Some
    Clindamycin (as clindamycin hydrochloride) 75 mg/mL oral suspension Count of base of active ingredient False un Inferred relationship Some
    Clindamycin (as clindamycin hydrochloride) 75 mg/mL oral suspension Has concentration strength denominator value False un Inferred relationship Some 1
    Product containing precisely promethazine hydrochloride 5 milligram/1 milliliter conventional release oral solution (clinical drug) Has concentration strength denominator value False un Inferred relationship Some 1
    Product containing precisely promethazine hydrochloride 5 milligram/1 milliliter conventional release oral solution (clinical drug) Count of base of active ingredient False un Inferred relationship Some
    Selegiline 500 microgram/hour prolonged-release transdermal patch Count of base of active ingredient False un Inferred relationship Some
    Selegiline 500 microgram/hour prolonged-release transdermal patch Has concentration strength denominator value False un Inferred relationship Some 1
    Product containing precisely boric acid 10 milligram/1 milliliter conventional release eye solution (clinical drug) Count of base of active ingredient False un Inferred relationship Some
    Product containing precisely boric acid 10 milligram/1 milliliter conventional release eye solution (clinical drug) Has concentration strength denominator value False un Inferred relationship Some 1
    Product containing precisely oxybutynin 162 microgram/1 hour prolonged-release transdermal patch (clinical drug) Has concentration strength denominator value False un Inferred relationship Some 1
    Product containing precisely oxybutynin 162 microgram/1 hour prolonged-release transdermal patch (clinical drug) Count of base of active ingredient False un Inferred relationship Some
    Thioridazine 2 mg/mL oral solution Has concentration strength denominator value False un Inferred relationship Some 1
    Thioridazine 2 mg/mL oral solution Count of base of active ingredient False un Inferred relationship Some
    Codeine phosphate 2 mg/mL and promethazine hydrochloride 1.25 mg/mL oral solution Has concentration strength denominator value False un Inferred relationship Some 2
    Codeine phosphate 2 mg/mL and promethazine hydrochloride 1.25 mg/mL oral solution Has concentration strength denominator value False un Inferred relationship Some 1
    Product containing precisely trimethobenzamide (as trimethobenzamide hydrochloride) 200 milligram/1 each conventional release rectal suppository (clinical drug) Count of base of active ingredient False un Inferred relationship Some
    Product containing precisely trimethobenzamide (as trimethobenzamide hydrochloride) 200 milligram/1 each conventional release rectal suppository (clinical drug) Has presentation strength denominator value False un Inferred relationship Some 1
    Product containing precisely selegiline hydrochloride 1.25 milligram/1 each conventional release orodispersible tablet (clinical drug) Count of base of active ingredient False un Inferred relationship Some
    Product containing precisely selegiline hydrochloride 1.25 milligram/1 each conventional release orodispersible tablet (clinical drug) Has presentation strength denominator value False un Inferred relationship Some 1
    Product containing precisely naproxen (as naproxen sodium) 375 milligram/1 each gastro-resistant oral tablet (clinical drug) Has presentation strength denominator value False un Inferred relationship Some 1
    Product containing precisely naproxen (as naproxen sodium) 375 milligram/1 each gastro-resistant oral tablet (clinical drug) Count of base of active ingredient False un Inferred relationship Some
    Product containing precisely prednisolone 5 milligram/1 each conventional release orodispersible tablet (clinical drug) Count of base of active ingredient False un Inferred relationship Some
    Product containing precisely prednisolone 5 milligram/1 each conventional release orodispersible tablet (clinical drug) Has presentation strength denominator value False un Inferred relationship Some 1
    Product containing precisely fluorescein sodium stain 2.5 milligram/1 milliliter and proxymetacaine hydrochloride 5 milligram/1 milliliter conventional release eye solution (clinical drug) Has concentration strength denominator value False un Inferred relationship Some 2
    Product containing precisely fluorescein sodium stain 2.5 milligram/1 milliliter and proxymetacaine hydrochloride 5 milligram/1 milliliter conventional release eye solution (clinical drug) Has concentration strength denominator value False un Inferred relationship Some 1
    Product containing precisely methylprednisolone 40 milligram/1 vial powder for conventional release solution for injection (clinical drug) Count of base of active ingredient False un Inferred relationship Some
    Product containing precisely methylprednisolone 40 milligram/1 vial powder for conventional release solution for injection (clinical drug) Has presentation strength denominator value False un Inferred relationship Some 1
    Tiotixene 5 mg/mL oral solution Has concentration strength denominator value False un Inferred relationship Some 1
    Tiotixene 5 mg/mL oral solution Count of base of active ingredient False un Inferred relationship Some
    Product containing precisely mesoridazine 25 milligram/1 milliliter conventional release solution for injection (clinical drug) Count of base of active ingredient False un Inferred relationship Some
    Product containing precisely mesoridazine 25 milligram/1 milliliter conventional release solution for injection (clinical drug) Has concentration strength denominator value False un Inferred relationship Some 1
    Cocaine (as cocaine hydrochloride) 20 mg/mL and homatropine hydrobromide 20 mg/mL eye solution Has concentration strength denominator value False un Inferred relationship Some 1
    Cocaine (as cocaine hydrochloride) 20 mg/mL and homatropine hydrobromide 20 mg/mL eye solution Has concentration strength denominator value False un Inferred relationship Some 2
    Thioridazine 30 mg/mL oral solution Count of base of active ingredient False un Inferred relationship Some
    Thioridazine 30 mg/mL oral solution Has concentration strength denominator value False un Inferred relationship Some 1
    Codeine phosphate 2 mg/mL and phenylephrine hydrochloride 1 mg/mL and promethazine hydrochloride 1.25 mg/mL oral solution Has concentration strength denominator value False un Inferred relationship Some 3
    Codeine phosphate 2 mg/mL and phenylephrine hydrochloride 1 mg/mL and promethazine hydrochloride 1.25 mg/mL oral solution Has concentration strength denominator value False un Inferred relationship Some 2
    Codeine phosphate 2 mg/mL and phenylephrine hydrochloride 1 mg/mL and promethazine hydrochloride 1.25 mg/mL oral solution Has concentration strength denominator value False un Inferred relationship Some 1
    Product containing precisely prednisolone (as prednisolone sodium phosphate) 3 milligram/1 milliliter conventional release eye solution (clinical drug) Has concentration strength denominator value False un Inferred relationship Some 1
    Product containing precisely prednisolone (as prednisolone sodium phosphate) 3 milligram/1 milliliter conventional release eye solution (clinical drug) Count of base of active ingredient False un Inferred relationship Some
    Product containing precisely sodium thiosalicylate 50 milligram/1 milliliter conventional release solution for injection (clinical drug) Has concentration strength denominator value False un Inferred relationship Some 1
    Product containing precisely sodium thiosalicylate 50 milligram/1 milliliter conventional release solution for injection (clinical drug) Count of base of active ingredient False un Inferred relationship Some
    Product containing precisely physostigmine sulfate 10 milligram/1 milliliter conventional release eye solution (clinical drug) Has concentration strength denominator value False un Inferred relationship Some 1
    Product containing precisely physostigmine sulfate 10 milligram/1 milliliter conventional release eye solution (clinical drug) Count of base of active ingredient False un Inferred relationship Some
    Product containing precisely bretylium 50 milligram/1 milliliter conventional release solution for injection (clinical drug) Has concentration strength denominator value False un Inferred relationship Some 1
    Product containing precisely bretylium 50 milligram/1 milliliter conventional release solution for injection (clinical drug) Count of base of active ingredient False un Inferred relationship Some
    Buprenorphine 2 mg and naloxone hydrochloride 500 microgram sublingual tablet Has presentation strength denominator value False un Inferred relationship Some 1
    Buprenorphine 2 mg and naloxone hydrochloride 500 microgram sublingual tablet Has presentation strength denominator value False un Inferred relationship Some 2
    Product containing precisely tetracycline 25 milligram/1 milliliter conventional release oral solution (clinical drug) Count of base of active ingredient False un Inferred relationship Some
    Product containing precisely tetracycline 25 milligram/1 milliliter conventional release oral solution (clinical drug) Has concentration strength denominator value False un Inferred relationship Some 1
    Selegiline 375 microgram/hour prolonged-release transdermal patch Has concentration strength denominator value False un Inferred relationship Some 1
    Selegiline 375 microgram/hour prolonged-release transdermal patch Count of base of active ingredient False un Inferred relationship Some
    Product containing precisely zolmitriptan 5 milligram/1 actuation conventional release nasal spray (clinical drug) Count of base of active ingredient False un Inferred relationship Some
    Hyoscyamine sulfate 25 microgram/mL oral solution Count of base of active ingredient False un Inferred relationship Some
    Hyoscyamine sulfate 25 microgram/mL oral solution Has concentration strength denominator value False un Inferred relationship Some 1
    Product containing precisely mercaptamine 1 milligram/1 milliliter conventional release eye solution (clinical drug) Has concentration strength denominator value False un Inferred relationship Some 1
    Product containing precisely mercaptamine 1 milligram/1 milliliter conventional release eye solution (clinical drug) Has concentration strength numerator value False un Inferred relationship Some 1
    Product containing precisely mercaptamine 1 milligram/1 milliliter conventional release eye solution (clinical drug) Count of base of active ingredient False un Inferred relationship Some
    Methylphenidate hydrochloride 5 mg chewable tablet Count of base of active ingredient False un Inferred relationship Some
    Methylphenidate hydrochloride 5 mg chewable tablet Has presentation strength denominator value False un Inferred relationship Some 1
    Product containing precisely filgrastim 300 microgram/1 milliliter conventional release solution for injection (clinical drug) Count of base of active ingredient False un Inferred relationship Some
    Product containing precisely filgrastim 300 microgram/1 milliliter conventional release solution for injection (clinical drug) Has concentration strength denominator value False un Inferred relationship Some 1
    Product containing precisely human immunoglobulin G 5 gram/1 vial powder for conventional release solution for injection (clinical drug) Count of base of active ingredient False un Inferred relationship Some
    Product containing precisely human immunoglobulin G 5 gram/1 vial powder for conventional release solution for injection (clinical drug) Has presentation strength denominator value False un Inferred relationship Some 1
    Cyclopentolate hydrochloride 10 mg/mL eye solution Has concentration strength denominator value False un Inferred relationship Some 1
    Cyclopentolate hydrochloride 10 mg/mL eye solution Count of base of active ingredient False un Inferred relationship Some
    Phenoxymethylpenicillin potassium 3 mg/mL eye solution Count of base of active ingredient False un Inferred relationship Some
    Phenoxymethylpenicillin potassium 3 mg/mL eye solution Has concentration strength denominator value False un Inferred relationship Some 1
    Quinine 300 mg/mL solution for injection Has concentration strength denominator value False un Inferred relationship Some 1
    Quinine 300 mg/mL solution for injection Count of base of active ingredient False un Inferred relationship Some
    Product containing precisely phenylephrine hydrochloride 1.25 milligram/1 milliliter conventional release nasal solution (clinical drug) Has concentration strength denominator value False un Inferred relationship Some 1
    Product containing precisely phenylephrine hydrochloride 1.25 milligram/1 milliliter conventional release nasal solution (clinical drug) Count of base of active ingredient False un Inferred relationship Some
    Product containing precisely abatacept 250 milligram/1 vial powder for conventional release solution for injection (clinical drug) Count of base of active ingredient False un Inferred relationship Some
    Product containing precisely abatacept 250 milligram/1 vial powder for conventional release solution for injection (clinical drug) Has presentation strength denominator value False un Inferred relationship Some 1
    Cyclopentolate hydrochloride 20 mg/mL eye solution Has concentration strength denominator value False un Inferred relationship Some 1
    Cyclopentolate hydrochloride 20 mg/mL eye solution Count of base of active ingredient False un Inferred relationship Some
    Product containing precisely loperamide hydrochloride 200 microgram/1 milliliter conventional release oral solution (clinical drug) Has concentration strength denominator value False un Inferred relationship Some 1
    Product containing precisely loperamide hydrochloride 200 microgram/1 milliliter conventional release oral solution (clinical drug) Count of base of active ingredient False un Inferred relationship Some
    Product containing precisely phenobarbital 4 milligram/1 milliliter conventional release oral solution (clinical drug) Has concentration strength denominator value False un Inferred relationship Some 1
    Product containing precisely phenobarbital 4 milligram/1 milliliter conventional release oral solution (clinical drug) Count of base of active ingredient False un Inferred relationship Some
    Product containing precisely phenylephrine hydrochloride 2.5 milligram/1 milliliter conventional release nasal solution (clinical drug) Has concentration strength denominator value False un Inferred relationship Some 1
    Product containing precisely phenylephrine hydrochloride 2.5 milligram/1 milliliter conventional release nasal solution (clinical drug) Count of base of active ingredient False un Inferred relationship Some
    Product containing precisely ranibizumab 10 milligram/1 milliliter conventional release solution for injection (clinical drug) Count of base of active ingredient False un Inferred relationship Some
    Product containing precisely ranibizumab 10 milligram/1 milliliter conventional release solution for injection (clinical drug) Has concentration strength denominator value False un Inferred relationship Some 1
    Product containing precisely polyvinyl alcohol 14 microliter/1 milliliter conventional release eye solution (clinical drug) Count of base of active ingredient False un Inferred relationship Some
    Product containing precisely polyvinyl alcohol 14 microliter/1 milliliter conventional release eye solution (clinical drug) Has concentration strength denominator value False un Inferred relationship Some 1
    Levocetirizine dihydrochloride 500 microgram/mL oral solution Has concentration strength denominator value False un Inferred relationship Some 1
    Levocetirizine dihydrochloride 500 microgram/mL oral solution Count of base of active ingredient False un Inferred relationship Some
    Product containing precisely clemastine fumarate 134 microgram/1 milliliter conventional release oral solution (clinical drug) Has concentration strength denominator value False un Inferred relationship Some 1
    Product containing precisely clemastine fumarate 134 microgram/1 milliliter conventional release oral solution (clinical drug) Count of base of active ingredient False un Inferred relationship Some
    Trifluoperazine 10 mg/mL oral solution Has concentration strength denominator value False un Inferred relationship Some 1
    Trifluoperazine 10 mg/mL oral solution Count of base of active ingredient False un Inferred relationship Some
    Propranolol hydrochloride 16 mg/mL oral solution Has concentration strength denominator value False un Inferred relationship Some 1
    Propranolol hydrochloride 16 mg/mL oral solution Count of base of active ingredient False un Inferred relationship Some
    Phenylephrine hydrochloride 10 mg/mL nasal solution Has concentration strength denominator value False un Inferred relationship Some 1
    Phenylephrine hydrochloride 10 mg/mL nasal solution Count of base of active ingredient False un Inferred relationship Some

    Start Previous Page 191 of 215 Next End

    Reference Sets

    Concept inactivation indicator reference set

    Back to Start